Core Viewpoint - The legal opinion letter from Beijing Wan Shang Tian Qin Law Firm confirms that the procedures for the convening and holding of Jiangsu Lanfeng Bio-chemical Co., Ltd.'s 2025 first extraordinary general meeting of shareholders comply with relevant laws and regulations [2][4][6]. Group 1: Meeting Procedures - The extraordinary general meeting was convened by the company's board of directors, with the decision made on July 28, 2025, to hold the meeting on August 15, 2025 [2][3]. - A notice regarding the meeting was published on July 30, 2025, detailing the convenor, meeting time, method, and other relevant matters [3]. - The meeting utilized a combination of on-site voting and online voting, with specific time slots allocated for each method [3]. Group 2: Attendance and Voting - A total of 132 shareholders and their representatives attended the meeting, representing 113,326,555 shares, which is 30.1978% of the total shares [4]. - Of the attendees, 8 were present at the on-site meeting, representing 107,278,555 shares (28.5862%), while 124 participated via online voting, representing 6,048,000 shares (1.6116%) [4]. - The voting results showed that the proposals were overwhelmingly approved, with significant majorities in favor [6][8]. Group 3: Voting Results - The first proposal received 73,537,532 votes in favor, accounting for 98.2788% of the votes cast [5]. - The second proposal was approved with 113,139,155 votes in favor, representing 99.8346% of the total votes [6]. - The third proposal also passed with 113,144,455 votes in favor, which is 99.8393% of the total votes [8]. Group 4: Conclusion - The law firm concluded that all aspects of the meeting, including the convening procedures, qualifications of attendees, and voting processes, were in compliance with legal and regulatory requirements, rendering the resolutions valid [6].

北京市万商天勤律师事务所 关于 江苏蓝丰生物化工股份有限公司 2025 年第一次临时股东会 的法律意见书 北京市朝阳区建国门外大街 8 号北京国际财源中心 A 座 32 层 100022 电话: +86 10 82255588 www.vtlaw.cn 北京 深圳 上海 成都 武汉 西安 长沙 杭州 海口 南京 广州 香港(联营) 昆明 福州 北京市万商天勤律师事务所 关于江苏蓝丰生物化工股份有限公司 2025 年第一次临时股东会的 法律意见书 致：江苏蓝丰生物化工股份有限公司 根据《中华人民共和国证券法》《中华人民共和国公司法》及中国证券监督管理 委员会《上市公司股东会规则》（以下简称《股东会规则》）《深圳证券交易所上市 公司股东会网络投票实施细则》等法律、法规和规范性文件的规定，北京市万商天勤 律师事务所（以下称"本所"）接受江苏蓝丰生物化工股份有限公司（以下简称"公 司"）的委托，指派律师现场出席公司 2025 年第一次临时股东会，并出具法律意见。 本所律师同意将本法律意见书随公司本次股东会决议一并予以公告，并依法对本 法律意见书承担相应的责任。 本所律师根据《股东会规则》第六条的要求，按照律师行业公认 ...

江苏蓝丰生物化工股份有限公司 2025 年第一次临时股东会决议公告 本公司及董事会全体成员保证公告内容真实、准确和完整，不存在虚假记 载、误导性陈述或者重大遗漏。 一、特别提示： 1、本次股东会未出现否决议案的情形。 证券代码：002513 证券简称：蓝丰生化 公告编号：2025-037 2、本次股东会不涉及变更前次股东会决议。 二、会议召开情况 1、会议召开方式：本次股东会采用现场投票与网络投票相结合的方式。 2、召开时间 （1）现场会议召开时间为：2025 年 8 月 15 日（星期五）下午 14：30。 （2）网络投票时间为：2025 年 8 月 15 日。其中： ①通过深圳证券交易所交易系统进行网络投票的具体时间为：2025 年 8 月 15 日 9：15～9：25、9：30～11：30、13：00～15：00； ②通过深圳证券交易所互联网投票系统投票的具体时间为：2025 年 8 月 15 日上午 9：15 至下午 15：00 期间的任意时间。 3、现场会议召开地点：安徽省滁州市中新苏滁高新技术产业开发区建业路 1 号旭合科技办公楼 202 会议室。 4、召集人：江苏蓝丰生物化工股份有限公司董事会 ...

证券之星消息，8月14日农化制品板块较上一交易日下跌1.35%，宏达股份领跌。当日上证指数报收于 3666.44，下跌0.46%。深证成指报收于11451.43，下跌0.87%。农化制品板块个股涨跌见下表： 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。 | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | --- | --- | --- | --- | --- | --- | | 600331 | 宏达股份 | 10.02 | -5.47% | 63.40万 | 6.50亿 | | 870866 | 绿亭科技 | 9.52 | -4.42% | 3.56万 | 3457.43万 | | 002734 | 利民股份 | 21.65 | -4.12% | 38.98万 | 8.67 Z | | 002513 | 蓝丰生化 | 5.46 | -3.87% | 8.22万 | 4571.81万 | | 600596 | 新安股份 | 9.67 | -3.40% | 27.83万 | 2.74亿 | | 30 ...

Market Overview - The Shanghai Composite Index is at 3568.96 points with a change of 0.25% [1] - The total trading volume of A-shares is 11803.88 billion yuan [1] Technical Analysis - 42 A-shares have seen their 5-day moving average cross below the 10-day moving average [1] - Notable stocks with significant distance between their 5-day and 10-day moving averages include: - Sifang Precision (300468) with a distance of -1.65% [1] - Zhongyou Capital (000617) with a distance of -1.06% [1] - Langxin Group (300682) with a distance of -0.89% [1] Individual Stock Performance - Sifang Precision (300468) has decreased by 1.63% today with a turnover rate of 5.43% [1] - Zhongyou Capital (000617) has decreased by 3.65% today with a turnover rate of 1.65% [1] - Langxin Group (300682) has decreased by 0.86% today with a turnover rate of 1.91% [1] - Other stocks with notable performance include: - China Life Insurance (601319) with a slight increase of 0.12% [1] - Haosen Intelligent (688529) with an increase of 1.31% [1] - Donglai Technology (688129) with an increase of 1.88% [1] Additional Stock Data - Stocks showing a decrease in their 5-day moving average compared to the 10-day moving average include: - Mengjie (002397) down by 1.39% [1] - Greenland Holdings (600606) down by 0.53% [1] - Lida Xin (605365) down by 0.88% [1] - Stocks with minor changes include: - Jiemai (300868) down by 0.23% [2] - Lianchuang Electronics (002036) up by 0.19% [2] - ST Panda (600599) up by 0.26% [2]

Core Viewpoint - Jiangsu Lanfeng Biological Chemical Co., Ltd. is currently involved in a legal dispute regarding securities false statements, with a total claim amount of RMB 19.18 million from 163 investors [2][3][4]. Group 1: Lawsuit Basic Information - The company has previously disclosed information regarding the investor lawsuit related to securities false statements [3]. - The final judgment and civil rulings from the Nanjing Intermediate People's Court have been received concerning the claims from 45 investors [3]. Group 2: Lawsuit Progress - The Nanjing Intermediate People's Court has issued an execution ruling to freeze RMB 19.18 million of the company's bank deposits due to non-compliance with a prior civil judgment [4]. - A total of 8 bank accounts of the company have been frozen, with only RMB 77,400 actually frozen [4]. - The company's overall business operations remain normal and unaffected by the bank account freeze [4]. Group 3: Company Response - The company plans to raise funds to comply with the court ruling and compensate the investors, aiming to lift the freezing measures promptly [5]. - The company will pursue accountability against its former directors and senior management as per the administrative penalty decision issued by the China Securities Regulatory Commission [5]. Group 4: Financial Impact - The total amount related to the investor lawsuit and associated costs is approximately RMB 19.18 million, which will be accounted for as liabilities and losses according to accounting standards [7]. - The company will continue to monitor the lawsuit's progress and fulfill its information disclosure obligations [7].

证券代码：002513 证券简称：蓝丰生化 公告编号：2025-036 江苏蓝丰生物化工股份有限公司 关于投资者诉讼事项的进展公告 本公司及董事会全体成员保证公告内容真实、准确和完整，不存在虚假记 载、误导性陈述或者重大遗漏。 特别提示： 1、案件所处的阶段：执行阶段 2、上市公司所处的当事人地位：被执行人 1、申请执行人：宋敬杰等163名投资者 1 2、被执行人：江苏蓝丰生物化工股份有限公司 3、涉案的金额：人民币 1,918 万元 4、对上市公司损益产生的影响：涉诉案件相关判决涉及的赔偿金额，公司 将依据《企业会计准则》相关规定对投资者诉讼事项计提相应的负债和损益，具 体金额以审计结果为准。 一、诉讼基本情况 江苏蓝丰生物化工股份有限公司（以下简称"公司"或"蓝丰生化"）此 前已披露关于投资者诉公司证券虚假陈述责任纠纷的诉讼事项（以下简称"投 资者诉讼"）及进展情况，并收到江苏省高级人民法院送达的关于宋敬杰等 163名投资者诉讼索赔案件的终审判决以及江苏省南京市中级人民法院(以下简 称"南京中院")针对原告45名投资者与公司证券虚假陈述责任纠纷案件的民事 裁定书和民事判决书。具体内容请详见公司分别于202 ...

Group 1: Company Announcements - Zhixiang Jintai received approval for clinical trials of its drug, Sileweimi Monoclonal Antibody Injection, for passive immunity in children and adolescents exposed to suspected rabies virus [1] - Liyuan Technology's actual controller, Shen Wanzhong, received a criminal judgment for violating information disclosure laws, resulting in a one-year prison sentence with a one-and-a-half-year probation and a fine of 3.3 million yuan [1] - Shijia Photon reported a net profit of 217 million yuan for the first half of 2025, a year-on-year increase of 1712% [2] - Xinghua New Materials expects a net profit of 75 million to 85 million yuan for the first half of 2025, representing a year-on-year growth of 12.37% to 27.36% [3] - Greenland Holdings achieved a contract sales amount of 21.752 billion yuan in the second quarter, a year-on-year increase of 16.93% [4] Group 2: Shareholder Actions - Bluefeng Biochemical announced that a shareholder plans to reduce its stake by up to 2.61% [5] - Jiahe Meikang's shareholder intends to reduce its stake by up to 3% [5] - Lakaala reported that Lenovo Holdings reduced its stake by 535,960 shares, representing 0.68% of the total share capital [12] - Anji Food's controlling shareholder plans to reduce its stake by up to 2% [16] - Tongding Interconnect's shareholder plans to reduce its stake by up to 2.08% [20] Group 3: Strategic Partnerships and Investments - Yitian Intelligent signed distribution agreements with SMEG and Simico for a three-year period [6] - Daoshi Technology entered into a strategic cooperation agreement with Nengsida and Chipason to collaborate on materials for humanoid robot components [22]

本公司及董事会全体成员保证公告内容真实、准确和完整，不存在虚假记 载、误导性陈述或者重大遗漏。 一、董事会会议召开情况 证券代码：002513 证券简称：蓝丰生化 公告编号：2025-029 江苏蓝丰生物化工股份有限公司 江苏蓝丰生物化工股份有限公司（以下简称"公司"）第七届董事会第二十 四次会议于 2025 年 7 月 28 日以通讯表决方式召开。本次会议已于 2025 年 7 月 主持，应出席董事 8 人，实际出席董事 8 人，监事和高管列席会议。本次会议的 召集、召开及表决程序符合《公司法》和《公司章程》的规定，合法有效。 二、董事会会议审议情况 （一）审议通过《关于调整 2024 年限制性股票激励计划公司层面业绩考核 指标的议案》 本着兼顾战略目标达成和业绩可实现性，以及有效将股东利益、公司利益和 继续激励员工等目标的综合考虑，确保公司 2024 年限制性股票激励计划能顺利 实施，达到激励的效果。公司根据整体行业发展及公司运营实际情况，决定对 整。并相应修订《江苏蓝丰生物化工股份有限公司 2024 年限制性股票激励计划 （草案）》及其摘要、《江苏蓝丰生物化工股份有限公司 2024 年限制性股票激 励计 ...

一、监事会会议召开情况 江苏蓝丰生物化工股份有限公司（以下简称"公司"）第七届监事会第十九 次会议于 2025 年 7 月 28 日以通讯方式召开。本次会议通知已于 2025 年 7 月 25 日以微信、电子邮件的方式通知全体监事。本次会议由公司监事会主席韩宜辰先 生主持，应出席监事 3 人，实际出席监事 3 人。本次会议的召集、召开及表决程 序符合《公司法》和《公司章程》的规定，合法有效。 二、监事会会议审议情况 （一）审议通过《关于调整 2024 年限制性股票激励计划公司层面业绩考核 指标的议案》 证券代码：002513 证券简称：蓝丰生化 公告编号：2025-030 江苏蓝丰生物化工股份有限公司 本公司及监事会全体成员保证公告内容真实、准确和完整，不存在虚假记载、 误导性陈述或者重大遗漏。 经审核，监事会认为：公司对本激励计划中 2025 年和 2026 年公司层面业绩 考核指标的调整是基于公司目前行业发展状况和实际生产经营情况所做出的综 合考虑，目的是为更好地保障本激励计划的顺利实施，充分激发员工的内在动力 和潜能，符合《上市公司股权激励管理办法》等法律法规及本激励计划的相关规 定，调整程序合法、合规 ...